Skip to main content
. 2021 Dec 23;12:808012. doi: 10.3389/fimmu.2021.808012

Figure 4.

Figure 4

IL-1 family biologics. Schematic outlining current FDA-approved biologics targeting IL-1 family cytokines and signalling pathways that have demonstrated efficacy treating IL-1 cytokine-driven conditions.